Kaplan-Meier survival curves of OS and postbleed survival. (A) OS did not differ between the enoxaparin and control cohorts (log-rank P = .82). (B) Survival was significantly shorter after the diagnosis of a major ICH for patients on enoxaparin compared with patients not on anticoagulation (3.3 vs 10.2 months; log-rank P = .037). The enoxaparin cohort is represented by the red dashed line, and the control cohort is shown represented by blue solid line.